Paradromics, Elon Musk’s brain-tech rival, has successfully implanted a chip in a human subject for the first time, a ...

Recent gains in markets aren't likely to be indicative of a longer-term trajectory. Where stocks go will depend on where the ...

Recent gains in markets aren't likely to be indicative of a longer-term trajectory. Where stocks go will depend on where the ...

A new report by Sen. Elizabeth Warren itemizes 130 dodgy dealings by the man who calls himself the “Dogefather” ...

A 20-minute surgery marks a historic turning point for Paradromics as it begins its transition to clinical-stage neurotech.